HPSE and graft versus host disease: Interestingly, high levels of heparanase in recipients compared with donors have been associated with acute and chronic GvHD following HCT, suggesting a role for heparanase in hyperactivation of donor T cells toward recipient tissues and a potential rationale for heparanase-targeting treatments [52].